Tectonic Therapeutic IncNASDAQ:TECX
- LAST PRICE48.1000
- TODAY'S CHANGE (%)3.2100 (7.1508%)
- Bid / Lots47.9000/ 3
- Ask / Lots50.0000/ 2
- Open / Previous Close45.0400 / 44.8900
- Day Range
- 52 Week Range
- Volume112,547
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TECX |
|---|---|---|
| 09:32 ET | 544 | 44.56 |
| 09:33 ET | 300 | 44.995 |
| 09:35 ET | 400 | 45.69 |
| 09:37 ET | 100 | 45.17 |
| 09:42 ET | 500 | 44.99 |
| 09:44 ET | 300 | 45.47 |
| 09:46 ET | 100 | 45.295 |
| 09:53 ET | 100 | 45.245 |
| 09:57 ET | 200 | 45.245 |
| 10:02 ET | 397 | 45.22 |
| 10:04 ET | 1400 | 45.815 |
| 10:06 ET | 200 | 45.815 |
| 10:08 ET | 100 | 45.815 |
| 10:13 ET | 200 | 45.815 |
| 10:22 ET | 300 | 45.6212 |
| 10:29 ET | 400 | 45.99 |
| 10:38 ET | 900 | 46.215 |
| 10:40 ET | 720 | 46.225 |
| 10:42 ET | 800 | 46.2 |
| 10:44 ET | 2289 | 46.295 |
| 10:51 ET | 100 | 46.575 |
| 10:54 ET | 328 | 46.16 |
| 10:58 ET | 100 | 46.415 |
| 11:00 ET | 200 | 46.56 |
| 11:02 ET | 200 | 46.595 |
| 11:05 ET | 200 | 46.59 |
| 11:07 ET | 1497 | 46.78 |
| 11:18 ET | 650 | 47.13 |
| 11:20 ET | 382 | 47.09 |
| 11:21 ET | 100 | 47.11 |
| 11:23 ET | 1329 | 47.5118 |
| 11:27 ET | 100 | 47.41 |
| 11:41 ET | 100 | 47.63 |
| 11:48 ET | 200 | 46.63 |
| 11:56 ET | 100 | 47.62 |
| 12:01 ET | 200 | 47.62 |
| 12:10 ET | 500 | 47.62 |
| 12:15 ET | 100 | 47.62 |
| 12:17 ET | 4411 | 47.66 |
| 12:19 ET | 708 | 47.855 |
| 12:21 ET | 100 | 47.855 |
| 12:24 ET | 100 | 47.855 |
| 12:26 ET | 804 | 48.06 |
| 12:30 ET | 400 | 47.83 |
| 12:33 ET | 280 | 47.405 |
| 12:37 ET | 2050 | 47.56 |
| 12:42 ET | 200 | 47.84 |
| 12:46 ET | 123 | 47.489 |
| 12:51 ET | 451 | 47.87 |
| 01:08 ET | 900 | 47.86 |
| 01:13 ET | 447 | 47.94 |
| 01:22 ET | 100 | 48.21 |
| 01:24 ET | 208 | 48.0374 |
| 01:26 ET | 1013 | 48.26 |
| 01:33 ET | 100 | 48.205 |
| 01:36 ET | 550 | 48.245 |
| 01:44 ET | 5610 | 48.25 |
| 01:45 ET | 1878 | 47.585 |
| 01:49 ET | 800 | 47.645 |
| 01:51 ET | 100 | 47.615 |
| 01:54 ET | 400 | 47.615 |
| 01:56 ET | 1271 | 47.365 |
| 02:02 ET | 1100 | 47.03 |
| 02:07 ET | 100 | 46.9 |
| 02:09 ET | 266 | 46.875 |
| 02:25 ET | 100 | 46.985 |
| 02:27 ET | 400 | 47.18 |
| 02:30 ET | 400 | 47.16 |
| 02:32 ET | 3192 | 47.325 |
| 02:36 ET | 250 | 47.4816 |
| 02:39 ET | 100 | 47.44 |
| 02:41 ET | 200 | 47.6 |
| 02:48 ET | 100 | 47.445 |
| 02:56 ET | 100 | 47.595 |
| 02:57 ET | 350 | 47.645 |
| 02:59 ET | 100 | 47.7 |
| 03:08 ET | 100 | 47.48 |
| 03:10 ET | 100 | 47.5 |
| 03:14 ET | 100 | 47.6 |
| 03:19 ET | 396 | 47.535 |
| 03:21 ET | 300 | 47.485 |
| 03:24 ET | 1100 | 47.335 |
| 03:33 ET | 200 | 47.49 |
| 03:39 ET | 1269 | 47.75 |
| 03:50 ET | 324 | 47.97 |
| 03:51 ET | 700 | 47.86 |
| 03:53 ET | 1269 | 47.81 |
| 03:55 ET | 1620 | 47.82 |
| 03:57 ET | 614 | 47.86 |
| 04:00 ET | 8325 | 48.1 |
Nov 20, 2024
DJ Tectonic Therapeutic Initiated at Outperform by Raymond James, from 8:24AM ET on Wednesday Nov 20, 2024 by Dow Jones
8:24AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 12, 2024
DJ Tectonic Therapeutic Is Maintained at Overweight by Wells Fargo, from 9:48AM ET on Tuesday Nov 12, 2024 by Dow Jones
9:48AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 11, 2024
DJ Tectonic Therapeutic Is Maintained at Outperform by Leerink Partners, from 5:50PM ET on Monday Nov 11, 2024 by Dow Jones
5:50PM ET on Monday Nov 11, 2024 by Dow JonesTectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein, from 5:00AM ET on Monday Nov 11, 2024 by Dow Jones
5:00AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tectonic Therapeutic Inc | 661.4M | -3.5x | --- |
BIOAGE Labs Inc | 661.1M | -10.5x | --- |
Oric Pharmaceuticals Inc | 643.3M | -5.3x | --- |
Oculis Holding AG | 615.7M | -7.4x | --- |
Cullinan Therapeutics Inc | 711.5M | -4.4x | --- |
Oruka Therapeutics Inc | 717.5M | -3.5x | --- |
Company Information
Tectonic Therapeutic, Inc. is a biotechnology company. The Company is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its technology platform called GEODe (GPCRs Engineered for Optimal Discovery), the Company is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. The Company’s lead program, TX000045 (TX45), is an Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone relaxin. TX45 is being evaluated in Phase Ia/Ib clinical trials as a potential treatment for Group 2 Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (HFpEF). Its second program addresses Hereditary Hemorrhagic Telangiectasia (HHT).
Contact Information
- Headquarters
- 490 Arsenal Way, Suite 210WATERTOWN, MA, United States 02472
- Phone
- 339-666-3320
- Fax
- 302-655-5049
Executives
- President, Chief Executive Officer, Director
- Alise Reicin
- Chief Financial Officer
- Daniel Lochner
- Chief Scientific Officer
- Peter Mcnamara
- Chief Medical Officer
- Marcella Ruddy
- Chief Business Officer
- Marc Schwabish
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $661.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 14.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.16 |
EPS | $-13.91 |
Book Value | $25.46 |
P/E Ratio | -3.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
